These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28861789)

  • 1. Neurotoxicity of Prion Peptides on Cultured Cerebellar Neurons.
    Ciccotosto GD; Jana M; Cappai R
    Methods Mol Biol; 2017; 1658():147-165. PubMed ID: 28861789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of prion peptides on cultured cerebellar neurons.
    Ciccotosto GD; Cappai R; White AR
    Methods Mol Biol; 2008; 459():83-96. PubMed ID: 18576149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.
    Fioriti L; Angeretti N; Colombo L; De Luigi A; Colombo A; Manzoni C; Morbin M; Tagliavini F; Salmona M; Chiesa R; Forloni G
    J Neurosci; 2007 Feb; 27(7):1576-83. PubMed ID: 17301166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
    Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
    Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amidation and structure relaxation abolish the neurotoxicity of the prion peptide PrP106-126 in vivo and in vitro.
    Bergström AL; Cordes H; Zsurger N; Heegaard PM; Laursen H; Chabry J
    J Biol Chem; 2005 Jun; 280(24):23114-21. PubMed ID: 15824101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
    Brown DR
    Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
    Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
    J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
    Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
    J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
    Agostinho P; Lopes JP; Velez Z; Oliveira CR
    Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein aggregation and neurotoxicity in cortical neurons.
    Melo JB; Agostinho P; Oliveira CR
    Ann N Y Acad Sci; 2007 Jan; 1096():220-9. PubMed ID: 17405933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
    J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.
    Forloni G; Bugiani O; Tagliavini F; Salmona M
    Mol Chem Neuropathol; 1996; 28(1-3):163-71. PubMed ID: 8871955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
    Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
    J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.